Chiral Quest

Chiral Quest

Founded 2000 18 employees Series E Total: $43.20M Manufacturing, Pharmaceutical

Chiral Quest founded in 2000, is a leading player in the manufacturing and pharmaceutical industries, offering custom contract chemical development and manufacturing services. The company boasts an impressive track record, having developed over 400 intermediates for Active Pharmaceutical Ingredients, with four of them approved by the FDA. Chiral Quest operates a state-of-the-art R&D laboratory and a top-notch manufacturing facility. With a focus on asymmetric hydrogenation, multi-step synthesis, and cryogenic reactions, the company has established itself as a key supplier of chiral compounds on both small and large scales. In terms of infrastructure, Chiral Quest has a manufacturing site in Jiangxi province, China, while its Headquarters and R&D center are located in Suzhou Industrial Park, China. Furthermore, it has customer service offices in the USA, Europe, and India. With over 30 chemists, including several with advanced degrees, the company's R&D center is equipped to drive innovation, holding more than 20 patents in asymmetric catalysts and novel processes. The most recent milestone for Chiral Quest is its Series E investment secured on 19 October 2022. The round saw participation from notable investors including Addor Capital, IDG Capital, CDH Investments, and Raymond AMC. With a solid foundation and substantial investment support, Chiral Quest is poised for continued growth and success in the global pharmaceutical industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Series E	Undisclosed	4	Addor Capital, IDG Capital +2	19 Oct 2022
Series C	$23.00M	6	Infinity Equity Group, 上海开物股权投资管理有限公司 +4	08 Aug 2013
Series B	$13.00M	-		16 Jan 2009
Venture Round	$7.20M	-		26 Feb 2004

Funding Stage

Amount

Investors

Lead Investors

Date

Series E

Undisclosed

Addor Capital, IDG Capital +2

19 Oct 2022

Series C

$23.00M

Infinity Equity Group, 上海开物股权投资管理有限公司 +4

08 Aug 2013

Series B

$13.00M

16 Jan 2009

Venture Round

$7.20M

26 Feb 2004

FAQ About Chiral Quest

Chiral Quest, founded in 2000, serves the global pharmaceutical industry with custom contract chemical development and manufacturing services, from preclinical development to commercial supply. We have a state-of-the-art R&D laboratory equipped with modern analytical instruments, as well as a first...

Chiral Quest was founded in 2000.

Chiral Quest operates in Manufacturing and Pharmaceutical. Its work centres on pharmaceutical industry, contract chemical development, manufacturing services and R&D laboratory.

Chiral Quest has approximately 18 employees.

Chiral Quest has completed 4 funding rounds, raising a total of $43.20M. The latest funding stage is Series E.

Top alternatives and competitors to Chiral Quest include Archimica S.p.A, Flamma, Avra Laboratories Pvt Ltd, Keminntek, SEINE PHARMA PVT LTD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Chiral Quest and Archimica S.p.A are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Chiral Quest

Funding Rounds & Investors (4)

Chiral Quest Alternatives & Competitors

FAQ About Chiral Quest